ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
5.07
+0.36 (7.64%)
At close: Nov 20, 2024, 4:00 PM
4.860
-0.210 (-4.14%)
After-hours: Nov 20, 2024, 6:22 PM EST
ENDRA Life Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 4.85 | 5.52 | 6.6 | 6.02 | 5.58 | 4.27 | |
| Research & Development | 3.13 | 5 | 6.55 | 5.48 | 5.92 | 6.57 | |
| Operating Expenses | 7.98 | 10.52 | 13.16 | 11.5 | 11.5 | 10.84 | |
| Operating Income | -7.98 | -10.52 | -13.16 | -11.5 | -11.5 | -10.84 | |
| Interest Expense | - | - | - | - | -0.23 | -2.36 | |
| Other Non Operating Income (Expenses) | -1.02 | 0.46 | -0.02 | -0.04 | 0.01 | -0.11 | |
| EBT Excluding Unusual Items | -9 | -10.06 | -13.18 | -11.54 | -11.73 | -13.31 | |
| Other Unusual Items | - | - | - | 0.31 | - | - | |
| Pretax Income | -9 | -10.06 | -13.18 | -11.23 | -11.73 | -13.31 | |
| Net Income | -9 | -10.06 | -13.18 | -11.23 | -11.73 | -13.31 | |
| Preferred Dividends & Other Adjustments | - | - | - | 0.12 | 0.4 | 4.22 | |
| Net Income to Common | -9 | -10.06 | -13.18 | -11.35 | -12.12 | -17.53 | |
| Free Cash Flow | - | -9.58 | -12.97 | -11.17 | -10.82 | -8.63 | |
| EBITDA | -7.93 | -10.4 | -13.06 | -11.38 | -11.4 | -10.76 | |
| D&A For EBITDA | 0.05 | 0.12 | 0.1 | 0.12 | 0.1 | 0.08 | |
| EBIT | -7.98 | -10.52 | -13.16 | -11.5 | -11.5 | -10.84 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.